Patents by Inventor Earl R. Oberholtzer, Jr.

Earl R. Oberholtzer, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anhydrous alendronate monosodium salt formulations
    Patent number: 6008207
    Abstract: Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical doage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: December 28, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Gerald S. Brenner, Drazen Ostovic, Earl R. Oberholtzer, Jr., J. Eric Thies
  • Anhydrous alendronate monosodium salt formulations
    Patent number: 5849726
    Abstract: Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical dosage form of said anhydrous alendronate sodium, being anhydrous 4-amino-1-hydroxy-butylidene-1,1-bisphosphonic acid, monosodium salt, in a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: December 15, 1998
    Assignee: Merck & Co., Inc.
    Inventors: Gerald S. Brenner, Drazen Ostovic, Earl R. Oberholtzer, Jr., J. Eric Thies